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1157-23 Time Course Changes in Left Atrial Appendage 
Function, Lefi Atrial Size, and Spontaneous Echo 
Contrast After Balloon Mitral Valvuloplasty 
Kewal C. Goswami, Anandaraja Subramanian. Rakesh Yadav, Neil Bard&i, Kewal K. 
Talwar. All India Institute of Medical Sciences, New Delhi, India 
Background: Balloon mitral valvuloplasty (BMV) improves the depressed left atrial 
appendage (LAA) function. However no study has assessed the long-term changes in 
LAA function and left atnal (LA) size after BMV. 
Methods: LAA function (ejection fraction, filling &emptying velocities & their velocity tima 
integrals) and LA size were prospectively studied I” 100 consecutive severe mitral steno- 
sis patients (age 29.2k8.4 years. 52 males) by transesophageal echocardiography (TEE) 
24 hours before and after BMV, at 3 8 6 months, then at 6months intervals and com- 
pared with 20 controls. 
than grade l/4) mitral and/or aortic regurgitation (n=217). The remaining 1237 examina- 
tions were analysed. Results: There was no relationship between the MVA as assessed 
by PHT and the MVA derived from the continuity equation (r’ = 0.10043, p=“s) - see fig 
A. However, the continuity-derived MVA linearly decreased (r2 = 0.98) with increasing 
mea” pressure gradient (MPG). There was absolutely no relationship between MPG and 
PHT-derived MVA - see fig. 8. Conclusion: Transmitral PHT is of no use in the assess- 
ment of prosthetic mitral valves. However, MVA calculated via the continuity equation is 
linearly related to transmitral gradient and may be of use for sequential prosthesis fol- 
lowup. 
Results: LAA function and LA size during follow up is shown in table. 
Parameters before and after BMV 
March 19,2003 
Pre Post 3 12 24 36 - 48 Contra 
BMV BMV month month month months I 
s s S 
1157-26 
Mitral Vavle Area ( 0.78* 2.02*0 2.06* 2.07+0 2.04+0 2.04kO.3 
Serial Echocardiographic Follow-Up of Percutaneously 
Cd) 0.15 .28’ 0.31 .4 .34 8 
Implanted Pulmonary Valve in a Swine Model 
LA Area ( cd) 28.4+ 24.6+6 22.5r 20.6r6 19.2i6 18.4&O 13.0+ 
7.1 .6’ 6.1 .l .6 2.1 
LAA Ejection Fraction 39.3* 53.3+1 57.52 56.3~1 57.4*1 53.Oill. 6l.li 
(%) 11.6 2.1’ 12.9 3.2 0.5 6 10.2 
LAA Emptytng 20.02 32.7+1 33.0+ 31.6+9 35.9+1 35.0*11. 46.6* 
Velocity (cm/set) 8.4 0.8’ 12.0 .3 0.2 7 18.3 
Peter Varga, Motofumi lemura, Carlos E. Ruiz, University of lllinols at Chicago, Chicago, 
IL 
Background: The purpose of this study was to determine the short and intermedlate term 
function of percutaneously implanted self expanding stented valve in the pulmonary 
artery (PV) in a swine model by serial transthoracic echocardiography (TTE). 
Methods: Ten female farm pigs (6 - 20 Kg) underwent percutaneous stewing of their 
native pulmonary valve to create pulmonary insufficiency. All animals underwent percuta- 
LAA Filling Velocity 24.0* 35.9*1 36.7+ 35.2*1 40.6+1 38.3*10. 46.2+ 
(cm/sac) 11.1 1.6’ 14.9 2.4 3.8 9 21.6 
* p <O.OOl 
There was significant improvement in LAA function and it was maintained during follow 
up (FU) but did not reach control values. The Improvement in LAA function was more 
marked in patients who had post BMV area >1.5 cm*, sinus rhythm (NSR), and smaller 
LAA. LA area continued to decrease during FU and the decrease in LA area was more 
marked in patients who were in NSR. Spontaneous echo contrast disappeared in 50% 
and 80% of cases immediately after BMV and at last FU respectively. After BMV 33% of 
patients in atrial fibrillation reverted to NSR within 24 months. There was no WLAA clot 
detected during follow up. 
Conclusions: BMV favorably alters LAA function & LA size, which is maintained during 
FU. Organic involvement of the LAA precludes normalization of LAA function following 
BMV. Improved LAA function & LA size has favorable effect on LAILAA clot formation 
news implant of a self-expanding stented valve two lo four weeks later. All procedures 
were performed under fluoroscopic and transthoracic, real time echo guidance. Echocar- 
diagrams were performed pre and post valve implant and at 2 wks, 4 wks, 8 wks and 12 
wks post valve implant. All studies were found to be diagnostic quality by 2 pediatric car- 
diologlsts. 
Results: The RV systolic and diastoltc diameter (RVESD, RVEDD) and PA diameter 
(PAD) indexed to body weight (i) did not increase throughout the study period. There was 
a trend toward decreasing RV diameter/weight over time. Right ventricular hypertension 
(TR velocity measured at tips of tricuspid valve leaflets) developed in 3/l 0 pigs following 
valve implant and was mild at 8-12 wks post implant. There was perivalvar leak (mild) in 
3110 pigs. There was no implanted valve regurgitation in any of the animals. 
Conclusion: There was good valve function demonstrated on senal echocardiographic 
follow up of the implanted pulmonary valve without stenosis or insufficiency up lo 3 
months of follow up. There was no ewdence of thrombosis or endocardiw. 
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1157-24 Preliminary Report on Percutaneous Mechanical Mitral 
Commissurotomy Baseline 12 Weeks 
Tuan 0. Nouven. Khai G. Pham Viet L. Nguyen, Thai Q. Nguyen, Lich T. To, Thach N. 
Nguyen, Vietnam Heart Institute, Hanoi, Viet Nam, St. Mary Medical Center. Hobart, IN 
RVEDDi (mm/kg) 0.9 (range 0.6 - 1 .O) 0.5 (range 0.4 - 0.7) 
Background: Our first clinical experience on percutaneous mechanical mitral commis- 
RVESDi (mm/kg) 0.6 (range 0.5 0.8) 0.4 (range 0.3 - 0.5) 
surotomy (PMMC) consisted of 46 patients with mitral stenosis in which 13 patients with 
PADi (mm/kg) 0.9 (range 0.7 1.1) 0.6 (range 0.4 - 0.8) 
mitral restenasis after pnor surgical commissurotomy (38,26%). The mea” age was TR (mfs) 2.0 (range 0.9 - 2.6) 2.2 (range 1.4 - 3.0) 
45.52 * 10.5 years (17 to 70). The gender: 38 females and 8 males. 22 were in sinus 
rhythm and 24 presented with atrial fibrillation. The mea” total echo score was 9.81 * 2.3 
PV (m/s) 1 .I (range 0.8 - 1.9) 1.3 (range 0.7 - 1.8) 
and the majority in functional class (NYHA) III/IV (54.35%). Results: The procedures was 
technically successful in 46 patients (100%). PMMC resulted in significant improvement 
in hemodynamic values: the mea” left atrial pressure fell from 31 .10 * 7.22 mmHg to POSTER SESSION 
17.5 * 5.15 mmHg (p < 0.0001). the mea” transmitral gradient (MVG) droped from 17.24 
* 5.36 mmHa to 6.88 f 2. 74 mmHa f!xO.OOOl). and the mea” Pulmonarv “ressura fell _ _ 
from 52.93 * 19.14 mmHg lo 37.9 * 12.23 mmHg (pcO.0001). The mitral valve area 
(MVA) on 2D echo cardiography increased significantly from 0.89 * 0.21 cm2 to 2.02 * 
1182 Experimental Advances in Cardiac 
0.46 cm2 (p<O.OOOl), and on echo Doppler increased from 0.90 * 0.24 cm2 to 2.0 * 0.44 Surgery 
Cm2 (p<O.OOOl). Complications included 1 case with increasing of MR post PMMC 
(grade Ill), she then tolerated well with the medical therapy. Conclusion: The first results Tuesday, April 01, 2003, Noon-2:00 p.m. 
of this series attest to the effectiveness and usefulness of the PMMC with Cribier device McCormick Place, Hall A 
in Vietnam. Further clinical evaluation is on-going. Presentation Hour: Noon-l :00 p.m. 
1157-25 Mitral Valve Pressure Half-Time Does Not Predict the 
Effective Valve Area in Prosthetic Mitral Valves of All 
Types: A Review of 2,175 Prosthetic Mitral Valves 
Greoorv M. Scalia, Bonita Anderson, Darryl J. Burstow, The Prince Charles Hospital, 
Brisbane, Australia 
Background: Transmitral mitral continuous-wave pressure half-time (PHT) has been 
historically used to assess mitral valve area (MVA) in native mitral valve stenosis via the 
formula MVA (cm*) = 220/PHT (msec). Despite broad clinical usage, this formula has 
“ever been validated for prosthetic valves where the effective mitral valve area may not 
be in the stenotic range. Methods: This retrospective study evaluated 2175 various pros- 
thetic mitral valves over a 6 year period undergoing routine echocardiographic surveil- 
lance. This included ATS 547, Bjork-Shiley 51, Carpentier-Edwards 126,Hancock 
Sl,Lillihei-Kaster 36, Mosaic 31. Perimount 62, St Jude 1139, Starr-Edwards 47 and 
Xenotech 45. Exclusion criteria included Incomplete data (“=699) and significant (greater 
1182-21 Preoperative Predictive Risk Model for Mortality in 
Patients With Acute Type A Aortic Dissection 
Undergoing Surgery: Lessons From the International 
Registry of Acute Aortic Dissection (IRAD) 
Santi Trlmarchi, Christoph A. Nienaber, Vincenzo Rampoldi, Rajendra H. Mehta. 
Eduardo Bossone, Jeanna V. Cooper, Dean E. Smith, Jae K. Oh, Eric M. Isselbacher, 
Tom Suzuki, Kim A. Eagle, lstituto Policlinico S. Don&o, S. Don& Milanese, Italy. 
University of Michigan Medical Center. Coordinating Center for IRAD Investigators. Ann 
Arbor, Ml 
Background: Surgical treatment of acute type A dissection (AAD) is still associated with 
a considerable mortality A preoperative risk-predictive model may be helpful for optlmal 
management of AAD patients. Methods: We evaluated 526 of 1032 patients (mean age 
60*14 yrs, males 70%) enrolled in IRAD (1996.2001), who were operated on for AAD. 
Univariate associations with surgical mortality outcomes produced Chi-square values 
